vs
Side-by-side financial comparison of Mount Logan Capital Inc. (MLCI) and Prelude Therapeutics Inc (PRLD). Click either name above to swap in a different company.
Mount Logan Capital Inc. is the larger business by last-quarter revenue ($11.4M vs $6.5M, roughly 1.8× Prelude Therapeutics Inc). Mount Logan Capital Inc. runs the higher net margin — -117.5% vs -303.5%, a 186.0% gap on every dollar of revenue.
180 Degree Capital Corp. is a publicly traded registered closed-end management investment company.
MLCI vs PRLD — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $11.4M | $6.5M |
| Net Profit | $-13.4M | $-19.7M |
| Gross Margin | — | — |
| Operating Margin | -97.3% | -314.1% |
| Net Margin | -117.5% | -303.5% |
| Revenue YoY | — | 116.7% |
| Net Profit YoY | — | 38.9% |
| EPS (diluted) | $-1.64 | $-0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $11.4M | $6.5M | ||
| Q3 24 | — | $3.0M |
| Q3 25 | $-13.4M | $-19.7M | ||
| Q3 24 | — | $-32.3M |
| Q3 25 | -97.3% | -314.1% | ||
| Q3 24 | — | -1145.9% |
| Q3 25 | -117.5% | -303.5% | ||
| Q3 24 | — | -1075.7% |
| Q3 25 | $-1.64 | $-0.26 | ||
| Q3 24 | — | $-0.43 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $55.0M |
| Total DebtLower is stronger | $73.4M | — |
| Stockholders' EquityBook value | $131.2M | $58.5M |
| Total Assets | $1.6B | $94.8M |
| Debt / EquityLower = less leverage | 0.56× | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $55.0M | ||
| Q3 24 | — | $153.6M |
| Q3 25 | $73.4M | — | ||
| Q3 24 | — | — |
| Q3 25 | $131.2M | $58.5M | ||
| Q3 24 | — | $156.4M |
| Q3 25 | $1.6B | $94.8M | ||
| Q3 24 | — | $197.2M |
| Q3 25 | 0.56× | — | ||
| Q3 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-25.6M | $-19.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $-25.6M | $-19.1M | ||
| Q3 24 | — | $-27.3M |
| Q3 25 | — | — | ||
| Q3 24 | — | $-27.4M |
| Q3 25 | — | — | ||
| Q3 24 | — | -912.0% |
| Q3 25 | — | 0.0% | ||
| Q3 24 | — | 2.1% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
